Canaccord Adams
http://www.canaccordadams.com/default.htmCanaccord Adams is a leading independent financial services firm committed to fostering the entrepreneurial economy by bringing corporate and institutional clients unique perspective on global investment opportunities. With operations in research, sales and trading, and investment banking, their 225 professionals seek out emerging opportunities in their key sectors - Mining and Metals, Energy, Technology, Life Sciences, Real Estate and Gaming, Consumer and Industrial Growth. Located in nine offices internationally, their experienced team generates focused, actionable ideas that identify opportunity and facilitate growth.
View Older Stories View More Recent Stories
-
Morning Movers 10/22: HTE, SDXC, SXI, NYT, FFIV, SKX, JCG Higher; TQNT, WSTL, NWK, EPAX, AFFX, NCR Lower
-
Daily State of the Markets: Why the Dive?
-
Canaccord Adams Maintains a 'Hold' Rating on Pentair (PNR); Raises Price Target & Estimates
-
Canaccord Adams Maintains a 'Hold' Rating on Cree, Inc (CREE); Raises Price Target
-
Canaccord Adams Downgrades Astec Industries (ASTE) to Hold; Disappointing Qtr
-
Canaccord Adams Reiterates a 'Buy' Rating on NBTY (NTY), Adds to Best Ideas List
-
Canaccord Adams Assumes Coverage on Vascular Solutions (VASC) with a Buy
-
Canaccord Adams Reiterates a 'Buy' on NuVasive (NUVA), Raises PT
-
Canaccord Adams Raises Apple (AAPL) Price Target to $250
-
Google (GOOG) Is The Lone Bright Spot After Strong Q3 Results
-
Wall Street Giddy On Google (GOOG); Canaccord Adams Sets The Bar With $700 Price Target
-
Analyst Round-Up Intel (INTC): 25 Analysts Play Catch-Up (Raise Price Targets)
-
Canaccord Adams Reiterates a 'Buy' Rating on BioMimetic Therapeutics (BMTI); Raises PT
-
Canaccord Adams Reiterates a 'Buy' on Intel Corp (INTC); Raises Estimates
-
Canaccord Adams Reiterates a 'Hold' rating on Altera (ALTR); Raises 2009-10 Estimates
-
Canaccord Adams Upgrades Answers Corp (ANSW) to Buy - Details Inside
-
Canaccord Adams Upgrades Quicksilver Resources (KWK) to Buy
-
Daily State of the Markets: And Awaaay We Go!
-
Canaccord Adams Upgrades Answers Corp. (ANSW) to Buy
-
Canaccord Adams Maintains a 'Buy' on Onyx Pharmaceuticals (ONXX); Lowers PT & Estimates
-
Canaccord Adams Maintains a 'Buy' on GeoEye (GEOY); Raises Price Target
-
Canaccord Adams Maintains a 'Buy' rating on DigitalGlobe (DGI); Praises Price Target
-
Canaccord Adams Maintains a 'Buy' on New Gold (NGD); Raises PT
-
Canaccord Adams Upgrades WebMD (WBMD) to Buy
-
Canaccord Adams Initiates Coverage on Lime Energy (LIME) with a Speculative Buy; "One-Stop Shop" for Energy Efficiency Services
-
Canaccord Adams Reiterates a 'Buy' on Green Mountain Coffee (GMCR); Expects Strong Holiday
-
Canaccord Adams Maintains a 'Buy' on NetApp (NTAP); Raises PT & 2010-11 Estimates
-
Omeros (OMER) IPO Trades Lower
-
Analyst Round-Up Yamana (AUY): 3 Upgrades, Numerous Price Target Raises
-
Omeros (OMER) Prices IPO at $10, Low End of Range
-
Notable Analyst Rating Changes 10/7: BAC, KO, DIS, TWC Upgrade; STJ, TSM, ACV, LYG, RBN Downgrade
-
Canaccord Adams Downgrades St. Jude Medical Inc. (STJ) to Hold
-
David Moenning's Daily State of the Markets: Voting With Their Feet
-
Lime Energy (LIME) Completes Sale of 750K Over-Allotment Option Shares
-
David Moenning's Daily State of the Markets: Expecting Too Much?
-
Canaccord Adams Downgrades ResMed (RMD) to Hold
-
EnteroMedics (ETRM) to Offer 6.16M Shares at $0.80/Share
-
Canaccord Adams Lifts Price Target on Fuel Systems (FSYS) to $40
-
Canaccord Adams Initiates Coverage on Allergan (AGN) with a Buy; Global Leader with Robust Pipeline
-
Canaccord Adams Initiates Coverage on Solta Medical (SLTM) with a Buy
-
Canaccord Adams Initiates Coverage on Palomar Medical Technologies (PMTI) with a Buy
-
Canaccord Adams Initiates Coverage on Cynosure (CYNO) with a Buy
-
Canaccord Adams Initiates Coverage on Cutera (CUTR) with a Hold
-
Canaccord Adams Maintains a 'Buy' on Northern Oil and Gas (NOG); Raises PT
-
Canaccord Adams Maintains a 'Buy' on Brigham Exploration (BEXP); Raises Price Target
-
Canaccord Adams Maintains a 'Hold' on Companhia Vale do Rio Doce (VALE); Raises PT
-
Canaccord Adams Raises Price Target On Inverness Medical (IMA) to $49, Citing Pima System
-
Canaccord Adams Reiterates a 'Buy' on ATP Oil & Gas (ATPG); Attractively Priced Name To Own
-
Canaccord Adams Maintains a 'Buy' on Freeport McMoRan (FCX); Raises Target Price
-
Canaccord Adams Downgrades Cameco Corporation (CCJ) to Hold; Full Valuation
